Form D · Other Health Care
Trially Inc.
Kansas City, MO · CIK 0002080537
Offering snapshot reported Aug 21, 2025 · SEC filing
- Reported sold
- $4.77M Offering amount: $4.77M
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 8, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 21, 2025 | Initial | $4,765,025 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-555454
Source: Form D, filed Aug 21, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Thad Langford | Director |
| Kyle Mc Allister | Director, Executive |
| Trevor Welch | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
420 Nichols Road, 2 Nd Floor
Kansas City, MO, 64112
Kansas City, MO, 64112